🇰🇷 South Korea Country × Condition
gastric cancer Clinical Trials in South Korea
Active clinical trials for gastric cancer with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 1, Phase 1, Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇰🇷 South Korea
Active Trials in South Korea (3)
NCT05768932 Phase 1
Recruiting
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Enrollment
260 pts
Country
🇰🇷 South Korea
SillaJen, Inc.
View Trial → NCT05894824 Phase 1, Phase 2
Recruiting
T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Enrollment
58 pts
Country
🇰🇷 South Korea
Yonsei University
View Trial → NCT06608381 Phase 3
Recruiting
Comparison Partial Versus Total Omentectomy in Minimal Invasive Distal Gastrectomy for cT3/4a Gastric Cancer (KLASS-10)
Enrollment
440 pts
Country
🇰🇷 South Korea
Gangnam Severance Hospital
View Trial → Frequently Asked Questions
How many gastric cancer clinical trials are active in South Korea?
There are currently 3 active clinical trials for gastric cancer with sites in South Korea, of which 3 are actively recruiting patients.
How can I join a gastric cancer clinical trial in South Korea?
To join a gastric cancer clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are gastric cancer trials in South Korea?
Active gastric cancer trials in South Korea span Phase 1, Phase 1, Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.